Evotec SE vs Solid Biosciences Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Evotec SE and Solid Biosciences Inc. are worth about the same: $720 M and $713 M (market caps of Aug 1, 2026 for Evotec SE and Oct 30, 2026 for Solid Biosciences Inc.). Evotec SE's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- Both made a net loss: $212 M for Evotec SE and $174 M for Solid Biosciences Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Evotec SE EVT.DE · #10,960 in the world | Solid Biosciences Inc. SLDB · #11,013 in the world |
|---|---|---|
| Profile | ||
| Country | 🇩🇪 Germany | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | 1993 | 2013 |
| Size | ||
| Market cap | $720 M | $713 M |
| Revenue | $862 M | — |
| Net income | $-212 M | $-174 M▲ best |
| Employees | 4,952 | — |
| Valuation | ||
| Price to sales | 0.8× | — |
| Price to book | 0.7× | 4.0× |
| Free cash flow yield | -14.9%▲ best | -22.1% |
| Profitability | ||
| Gross margin | 14.4% | — |
| Operating margin | -17.9% | — |
| Net margin | -24.6% | — |
| Return on equity | -19.1%▲ best | -109.9% |
| Growth | ||
| Revenue growth | 2.1% | — |
| Revenue growth, 3 years a year | 5.7% | — |
| Cash | ||
| Free cash flow margin | -12.4% | — |
| Altman Z-score zone | — | — |
| Data as of | Market cap Aug 2026; ratios FY2024 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Evotec SE or Solid Biosciences Inc.?
Evotec SE and Solid Biosciences Inc. are worth about the same: $720 M and $713 M (market caps of Aug 1, 2026 for Evotec SE and Oct 30, 2026 for Solid Biosciences Inc.). Evotec SE's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, Evotec SE or Solid Biosciences Inc.?
Both made a net loss: $212 M for Evotec SE and $174 M for Solid Biosciences Inc.
More about Evotec SE
More about Solid Biosciences Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.